Home/Filings/4/0001567619-21-018473
4//SEC Filing

Matthews Christine 4

Accession 0001567619-21-018473

CIK 0001587221other

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 9:35 PM ET

Size

7.2 KB

Accession

0001567619-21-018473

Insider Transaction Report

Form 4
Period: 2021-10-15
Matthews Christine
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2021-10-15+56,250154,541 total
  • Award

    Stock Option (Right to Buy)

    2021-10-15+112,500112,500 total
    Exercise: $0.63Exp: 2031-10-14Common Stock (112,500 underlying)
Footnotes (3)
  • [F1]Represents Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the completion of performance vesting.
  • [F2]Includes 56,250 RSUs which are subject to performance vesting.
  • [F3]The shares subject to the stock option vest and become exercisable in accordance with a performance vesting schedule.

Documents

1 file

Issuer

Zosano Pharma Corp

CIK 0001587221

Entity typeother

Related Parties

1
  • filerCIK 0001799864

Filing Metadata

Form type
4
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 9:35 PM ET
Size
7.2 KB